BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 30039310)

  • 1. Exploring pitfalls of
    Striese F; Sihver W; Gao F; Bergmann R; Walther M; Pietzsch J; Steinbach J; Pietzsch HJ
    Amino Acids; 2018 Oct; 50(10):1415-1431. PubMed ID: 30039310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of [64Cu]Cu-NOTA-Bn-GE11 for PET imaging of EGFR-rich tumors.
    Dejesus OT
    Curr Radiopharm; 2012 Jan; 5(1):15-8. PubMed ID: 21864245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein.
    Miao Z; Ren G; Liu H; Jiang L; Cheng Z
    Bioconjug Chem; 2010 May; 21(5):947-54. PubMed ID: 20402512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin α
    Li H; Peng W; Zhen Z; Zhang W; Liao S; Wu X; Wang L; Xuan A; Gao Y; Xu J
    Nucl Med Biol; 2023; 124-125():108364. PubMed ID: 37591041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of (68)Ga-labeled NOTA-RGD-GE11 heterodimeric peptide for dual integrin and epidermal growth factor receptor-targeted tumor imaging.
    Yu HM; Chen JH; Lin KL; Lin WJ
    J Labelled Comp Radiopharm; 2015 Jun; 58(7):299-303. PubMed ID: 25997858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.
    Ait-Mohand S; Fournier P; Dumulon-Perreault V; Kiefer GE; Jurek P; Ferreira CL; Bénard F; Guérin B
    Bioconjug Chem; 2011 Aug; 22(8):1729-35. PubMed ID: 21761921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.
    Kumar SR; Gallazzi FA; Ferdani R; Anderson CJ; Quinn TP; Deutscher SL
    Cancer Biother Radiopharm; 2010 Dec; 25(6):693-703. PubMed ID: 21204764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Analysis of
    Paiva I; Mattingly S; Wuest M; Leier S; Vakili MR; Weinfeld M; Lavasanifar A; Wuest F
    Mol Pharm; 2020 May; 17(5):1470-1481. PubMed ID: 32233491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of [
    Li X; Hu K; Liu W; Wei Y; Sha R; Long Y; Han Y; Sun P; Wu H; Li G; Tang G; Huang S
    Nucl Med Biol; 2020; 90-91():84-92. PubMed ID: 33189948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.
    Roosenburg S; Laverman P; Joosten L; Cooper MS; Kolenc-Peitl PK; Foster JM; Hudson C; Leyton J; Burnet J; Oyen WJ; Blower PJ; Mather SJ; Boerman OC; Sosabowski JK
    Mol Pharm; 2014 Nov; 11(11):3930-7. PubMed ID: 24992368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
    J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculature.
    Merrill JR; Krajewski K; Yuan H; Frank JE; Lalush DS; Patterson C; Veleva AN
    Biomaterials; 2016 Apr; 84():241-249. PubMed ID: 26839954
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kruziki MA; Case BA; Chan JY; Zudock EJ; Woldring DR; Yee D; Hackel BJ
    Mol Pharm; 2016 Nov; 13(11):3747-3755. PubMed ID: 27696863
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Kwon LY; Scollard DA; Reilly RM
    Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Tumor Pretargeting System Based on Complementary l-Configured Oligonucleotides.
    Schubert M; Bergmann R; Förster C; Sihver W; Vonhoff S; Klussmann S; Bethge L; Walther M; Schlesinger J; Pietzsch J; Steinbach J; Pietzsch HJ
    Bioconjug Chem; 2017 Apr; 28(4):1176-1188. PubMed ID: 28222590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.
    Chen K; Ma W; Li G; Wang J; Yang W; Yap LP; Hughes LD; Park R; Conti PS
    Mol Pharm; 2013 Jan; 10(1):417-27. PubMed ID: 23190134
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Pyo A; Yun M; Kim HS; Kim TY; Lee JJ; Kim JY; Lee S; Kwon SY; Bom HS; Kim HS; Kim DY; Min JJ
    J Nucl Med; 2018 Feb; 59(2):340-346. PubMed ID: 28916621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature.
    Chen K; Sun X; Niu G; Ma Y; Yap LP; Hui X; Wu K; Fan D; Conti PS; Chen X
    Mol Imaging Biol; 2012 Feb; 14(1):96-105. PubMed ID: 21360213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiopharmacological characterization of ⁶⁴Cu-labeled α-MSH analogs for potential use in imaging of malignant melanoma.
    Gao F; Sihver W; Jurischka C; Bergmann R; Haase-Kohn C; Mosch B; Steinbach J; Carta D; Bolzati C; Calderan A; Pietzsch J; Pietzsch HJ
    Amino Acids; 2016 Mar; 48(3):833-847. PubMed ID: 26643502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.